OptimizeRx
Stock Forecast, Prediction & Price Target
OptimizeRx Financial Estimates
OptimizeRx Revenue Estimates
OptimizeRx EBITDA Estimates
OptimizeRx Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $61.29M N/A | $62.45M 1.88% | $71.52M 14.52% | Avg: $112.63M Low: $108.99M High: $115.23M avg. 57.47% | Avg: $170.17M Low: $166.58M High: $173.91M avg. 51.08% | ||
Net Income
% change YoY
| $273.92K N/A | $-10.58M -3964.55% | $-17.56M -65.93% | Avg: $-10.73M Low: $-11.81M High: $-8.04M avg. 38.87% | Avg: $13.01M Low: $12.65M High: $13.38M avg. 221.21% | ||
EBITDA
% change YoY
| $2.44M N/A | $-10.26M -519.54% | $-21.30M -107.50% | Avg: $-8.30M Low: $-8.49M High: $-8.03M avg. 61.03% | Avg: $-12.54M Low: $-12.82M High: $-12.28M avg. -51.08% | ||
EPS
% change YoY
| $0.02 N/A | -$0.6 -3873.58% | -$1.03 -71.66% | Avg: -$0.57 Low: -$0.69 High: -$0.47 avg. 44.66% | Avg: $0.76 Low: $0.74 High: $0.78 avg. 233.33% | ||
Operating Expenses
% change YoY
| $35.27M N/A | $51.25M 45.29% | $69.30M 35.20% | Avg: $77.14M Low: $74.65M High: $78.93M avg. 11.31% | Avg: $116.56M Low: $114.09M High: $119.12M avg. 51.08% | ||
FAQ
What is OptimizeRx stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 130.04% in 2025-2026.
We have gathered data from 3 analysts. Their low estimate is -11.81M, average is -10.73M and high is -8.04M.
What is OptimizeRx stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 54.28% in 2025-2026.
We have gathered data from 5 analysts. Their low revenue estimate is $108.99M, average is $112.63M and high is $115.23M.
What is OptimizeRx stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 138.99% in 2025-2026.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$0.69, average is -$0.57 and high is $-0.47.
What is the best performing analyst?
In the last twelve months analysts have been covering OptimizeRx stock. The most successful analyst is Constantine Davides.